Fagron · 4 days ago
Account Manager, Specialty Sales
Fagron is a global market leader in personalized medicine, dedicated to improving lives through innovative pharmaceutical solutions. The Account Manager, Specialty Sales will focus on prospecting, closing, and managing accounts in the specialty sterile market, working closely with sales leadership to meet goals and grow business opportunities.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Increase profitable sales volume
Achieve assigned monthly sales goals
Research and identify sales prospects
Develop new account relationships/new business opportunities and maximize existing account relationships in assigned territory specific to growing the compounding business
Professionally represent Fagron and maximize sales opportunities at industry meetings, conferences, and conventions
Perform periodic business reviews (as required by sales leadership) within key accounts
Develop customer presentations for sales calls
Launch new products and innovation
Qualification
Required
Bachelor's degree in business, science, or related field required
Professional, positive, enthusiastic, entrepreneurial mindset and energetic attitude are a must
Strong negotiation skills coupled with excellent written and verbal communication skills
Solutions oriented and strong customer focus (internal and external)
Conflict resolution and problem-solving skills
Ability to thrive in a team environment coupled with a self-starter mindset
Ability to work independently is a must
Preferred
Minimum of 1+ years sales experience strongly preferred
Experience with Customer Relationship Management (CRM) tool strongly preferred
Benefits
Health, Vision, and Dental Insurance
Company Paid Life Insurance
Generous Paid Holidays
Paid Volunteer Time
Generous Paid Time Off and Rollover
Company matching 401K and Retirement Savings Plans
Employee Assistance Program
Flexible working arrangements
Company
Fagron
Fagron is committed to the personalization of health treatment to cover the individual patient’s need through Pharmaceutical Compounding & Sterile Outsourcing Services.
Funding
Current Stage
Public CompanyTotal Funding
$464.09MKey Investors
PGIM
2025-11-24Post Ipo Debt· $225M
2016-03-02Post Ipo Equity· $239.09M
2007-10-05IPO
Recent News
Company data provided by crunchbase